The market size value per capita for veterinary vaccines, excluding Foot and Mouth, in the UK has been on a downward trajectory from 2017, reaching $7.42 in 2023. This represents a year-on-year decline of approximately 2%, while over the last five years, a compound annual growth rate (CAGR) of around -2.1% is noted, indicating a sustained contraction in per capita spending on veterinary vaccines.
Looking ahead, market trends to watch include a potential shift towards novel vaccine technologies and growing demand for preventive veterinary care. Innovations in biotechnology and increased awareness of animal health could influence market recovery.
| # | 35 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 17.42 | 2023 | View data | ||
| 2 | 2 France | 14.92 | 2023 | View data | ||
| 3 | 3 Saudi Arabia | 9.73 | 2023 | View data | ||
| 4 | 4 Greece | 8.35 | 2023 | View data | ||
| 5 | 5 Portugal | 7.93 | 2023 | View data | ||
| 6 | 6 Canada | 7.69 | 2023 | View data | ||
| 7 | 7 United Kingdom | 7.42 | 2023 | |||
| 8 | 8 Costa Rica | 7.04 | 2023 | View data | ||
| 9 | 9 Ecuador | 6.74 | 2023 | View data | ||
